Santalum album cream - Santalis Healthcare

Drug Profile

Santalum album cream - Santalis Healthcare

Alternative Names: Albuterpenoid; East Indian sandalwood oil; EISO; SAN 007; VIR 003; VIR 007

Latest Information Update: 26 Sep 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator ViroXis
  • Developer Santalis Healthcare Corporation; Santalis Pharmaceuticals
  • Class Anti-infectives; Phytotherapies; Skin disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase II Atopic dermatitis; Condylomata acuminata; Molluscum contagiosum
  • No development reported Human papillomavirus infections; Poxvirus infections

Most Recent Events

  • 31 Aug 2018 Santalis Pharmaceuticals completes a phase II trial for Atopic dermatitis in USA (Topical) (NCT02871479)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Human-papillomavirus-infections in USA (Topical, Cream)
  • 04 Nov 2017 No recent reports of development identified for phase-I development in Poxvirus-infections in USA (Topical, Cream)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top